TrueWealth Advisors’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
Other funds holding ABBV
ECSS
ATO
TrueWealth Advisors's ABBV Position: Q2 2026 in Review
TrueWealth Advisors increased its AbbVie (ABBV) stake by 14% in Q2 2026, buying an estimated $77.9K and bringing the position to 2,974 shares worth $748K. The position accounts for 0.17% of the portfolio, ranked #115.
TrueWealth Advisors first reported a position in ABBV in Q4 2021 and has held it in 18 quarters since. 2,119 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.
- TrueWealth Advisors held 2,974 shares of AbbVie worth $748K as of Q2 2026.
- TrueWealth Advisors bought 362 AbbVie shares in Q2 2026, an estimated $77.9K.
- AbbVie made up 0.17% of TrueWealth Advisors's portfolio in Q2 2026, its #115 holding.
- TrueWealth Advisors first reported a position in AbbVie in Q4 2021 and has held it in 18 quarters since.
- 2,119 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.
Based on TrueWealth Advisors's 13F filing for Q2 2026, filed 8 Jul 2026.